Upgrade to SI Premium - Free Trial

Syndax Pharmaceuticals (SNDX)

18.35 +0.17 (0.94%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) September 4, 2026 4:01 PM - StreetInsider Syndax Announces Participation in September Investor Conferences September 1, 2026 7:00 AM - StreetInsider Syndax Pharmaceuticals (SNDX) PT Lowered to $33 at UBS as Revuforj New Starts Decline August 21, 2026 7:39 AM - StreetInsider Syndax Pharmaceuticals (SNDX) PT Lowered to $40 at JPMorgan August 11, 2026 8:49 AM - StreetInsider Form SCHEDULE 13G Syndax Pharmaceuticals Filed by: STATE STREET CORP August 7, 2026 11:00 AM - SEC Filing Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) August 5, 2026 4:01 PM - StreetInsider Syndax Pharmaceuticals (SNDX) PT Lowered to $38 at H.C. Wainwright August 5, 2026 6:37 AM - StreetInsider Syndax Pharmaceuticals (SNDX) PT Lowered to $26 at BofA Securities August 5, 2026 5:08 AM - StreetInsider Syndax Pharmaceuticals (SNDX) Misses Q2 EPS by 7c August 4, 2026 4:10 PM - StreetInsider Form 10-Q Syndax Pharmaceuticals For: Jun 30 August 4, 2026 4:05 PM - SEC Filing Form 8-K Syndax Pharmaceuticals For: Aug 04 August 4, 2026 4:03 PM - SEC Filing Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update August 4, 2026 4:01 PM - StreetInsider Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026 July 28, 2026 7:00 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX) July 15, 2026 7:38 AM - StreetInsider Form 8-K Syndax Pharmaceuticals For: Jul 14 July 14, 2026 8:31 AM - SEC Filing Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event July 14, 2026 8:00 AM - Globe NewsWire Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event July 14, 2026 8:00 AM - StreetInsider Form 4 Syndax Pharmaceuticals For: Jul 08 Filed by: Metzger Michael A July 9, 2026 4:54 PM - SEC Filing Form 144 Syndax Pharmaceuticals Filed by: Metzger Michael A July 8, 2026 4:39 PM - SEC Filing Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) July 1, 2026 4:01 PM - StreetInsider Full Article List